Langkau ke kandungan utama
Penerbitan

Immunoglobulin Accessibility For Patients With Primary Immunodeficiencies: Getting The Priorities Right— Dr Lokman Mohd Noh

Oleh #!30Sel, 02 Apr 2024 02:25:18 +0000p1830#30Sel, 02 Apr 2024 02:25:18 +0000p-2+00:003030+00:00x30 02am30am-30Sel, 02 Apr 2024 02:25:18 +0000p2+00:003030+00:00x302024Sel, 02 Apr 2024 02:25:18 +0000252254amSelasa=331#!30Sel, 02 Apr 2024 02:25:18 +0000p+00:004#April 2nd, 2024#!30Sel, 02 Apr 2024 02:25:18 +0000p1830#/30Sel, 02 Apr 2024 02:25:18 +0000p-2+00:003030+00:00x30#!30Sel, 02 Apr 2024 02:25:18 +0000p+00:004#Tiada komen1 min baca

🔍 “Ever wondered why access to Immunoglobulin Therapy is crucial for Primary Antibody Deficiency patients❓❔
Dr. Lokman Mohd Noh breaks it down – from the importance of antibodies to the challenges in availability.

Read the article written by CodeBlue below to gain more knowledge about it!
Article Link:

 

Langkau ke kandungan